Gimv

Complement Therapeutics operates as a preclinical stage company. Complement Therapeutics develops a precision medicine diagnostic platform allowing it to stratify patients based on their complement-activation profile with the potential to enable both patient selection and serving as an efficacy biomarker in future clinical studies.

Developer of antibody-based therapeutics intended to provide a new approach to treating fibrosis. The company engages in the development of therapeutics that target key fibrotic mediator proteins that aid in the development of fibrosis in chronically damaged organs, enabling medical practitioners to halt and reverse critical fibrosis and associated conditions.

ImCheck Therapeutics SAS is a biopharmaceutical company based in Marseille, France, founded in 2015. The company specializes in the development of immunotherapeutics aimed at addressing severe unmet medical needs, primarily in the field of immuno-oncology. ImCheck focuses on creating immuno-modulatory antibodies that target members of the butyrophilin super-family of checkpoint molecules, specifically engaging γ9δ2 T cells. Its research and development efforts are directed toward treating various cancers, including breast, gastric, and ovarian cancers, as well as other immune-related diseases. The company's innovative approach positions it at the forefront of next-generation immunotherapy solutions for patients suffering from solid tumors.

ImmunOs Therapeutics AG is a clinical-stage biotechnology company based in Schlieren, Switzerland, founded in 2014. The company specializes in the discovery and development of novel human immunomodulatory proteins aimed at enhancing cancer treatment and addressing autoimmune diseases. By focusing on next-generation therapeutics, ImmunOs aims to create drugs that not only exhibit direct anti-tumor effects but also remodel the tumor microenvironment. Additionally, the company is developing antibodies designed to block the activation of specific HLA molecules associated with autoimmune conditions. Through its innovative approach, ImmunOs Therapeutics seeks to improve the lives of patients suffering from serious diseases.

BioConnection B.V., based in Oss, the Netherlands, specializes in biopharmaceutical development and manufacturing services for small and medium-sized biopharmaceutical companies. Established in 2005, the company offers a comprehensive range of services, including clinical fill and finish, formulation development, and the manufacturing of active biopharmaceutical ingredients. BioConnection provides access to both small-scale clinical batch production and large-scale commercial facilities, ensuring compliance with good manufacturing practices (GMP). The company leverages a robust network of skilled suppliers and partners, including Merck & Co., to deliver expertise in the complete clinical development process. This support is particularly beneficial for young biopharmaceutical firms that may lack the facilities or experience necessary for effective drug development. BioConnection serves various needs, from personalized medications to clinical trial materials, making it a versatile partner in the biopharmaceutical landscape.

Camel-IDS develops radiopharmaceuticals for cancer patients. Its product, CAM-H2, treats HER2 positive cancers. It also engages in clinical development to treat breast cancer patients; and develops compounds for other cancer indications. The company was incorporated in 2014 and is based in Brussels, Belgium.

Anjarium Biosciences is a biotechnology company focused on engineering extracellular vesicles, particularly exosomes, to serve as advanced drug delivery systems for serious health conditions. By leveraging the natural communication network of the body, Anjarium transforms exosomes into effective therapeutic vehicles aimed at treating cancer and rare genetic diseases. Their proprietary Hybridosome® platform offers significant advantages in the design and application of these engineered exosomes, positioning the company at the forefront of developing targeted nanomedicines that could potentially improve patient outcomes in challenging therapeutic areas.

Topas Therapeutics GmbH is a biotechnology company based in Hamburg, Germany, focused on developing nanoparticle-based therapeutics to address significant unmet medical needs, particularly in autoimmune diseases, allergies, and anti-drug antibodies. The company utilizes its proprietary Topas Particle Conjugates technology platform to induce antigen-specific immune tolerance by leveraging the liver's natural immunological processes. This approach targets liver sinusoidal endothelial cells to promote tolerance against blood-borne antigens. Topas is advancing several clinical-stage programs, with its lead candidate, TPM203, currently in clinical testing for pemphigus vulgaris, an orphan disease. Other therapeutic programs under development include treatments for celiac disease, Type 1 diabetes, and multiple sclerosis. The company has established research collaborations with Eli Lilly and Company and Boehringer Ingelheim to enhance its capabilities in antigen-specific tolerance induction and anti-drug antibodies, respectively. Topas Therapeutics was incorporated in 2013 and is dedicated to finding innovative solutions for chronic immunological conditions.

Operator of integrated and maintenance services intended for construction, hospitals and data center companies. The company offers transformer substations, industrial automation, building distributors building services technology, electrical engineering and digitization services, thereby helping clients with quality assurance and process optimization.

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Verkley Groep B.V. is a contracting and engineering company based in Drachten, the Netherlands, specializing in the design and construction of both aboveground and underground infrastructures. The company serves a diverse clientele, including central governments, utility companies, municipal organizations, and commercial and industrial projects across Europe and North Africa. Verkley focuses on infrastructure related to gas, water, heating, communication, and electricity, in addition to street lighting and construction works adjacent to railways and motorways. Their expertise extends to the development of fire alarm systems, security systems, and data networks, as well as electrical installations for various sectors, including recreation and care institutions. The company also provides specialized services in pipeline construction, including drilling, pressure testing, and leak detection. Furthermore, Verkley offers consulting in pipeline engineering and feasibility studies for various industries, including gas, oil, and geothermal sectors.

Sofatutor GmbH is an edtech company that operates an online learning platform aimed at K-12 pupils and students in Europe. Founded in 2008 and based in Berlin, the platform, accessible at sofatutor.com, provides a comprehensive range of educational resources, including video lessons, practice problems, worksheets, and a homework chat feature. The subjects covered include mathematics, English, physics, chemistry, biology, and more, catering to students, teachers, and parents primarily in Germany and beyond. Sofatutor focuses on empowering students by providing them with the tools necessary to enhance their academic performance through engaging tutorials and interactive exercises.

Kinaset Therapeutics is a therapeutics company that focuses on the advancement of novel drugs in areas of unmet medical needs. The company was founded in 2020 and is headquartered in Medfield, Massachusetts.

Topas Therapeutics GmbH is a biotechnology company based in Hamburg, Germany, focused on developing nanoparticle-based therapeutics to address significant unmet medical needs, particularly in autoimmune diseases, allergies, and anti-drug antibodies. The company utilizes its proprietary Topas Particle Conjugates technology platform to induce antigen-specific immune tolerance by leveraging the liver's natural immunological processes. This approach targets liver sinusoidal endothelial cells to promote tolerance against blood-borne antigens. Topas is advancing several clinical-stage programs, with its lead candidate, TPM203, currently in clinical testing for pemphigus vulgaris, an orphan disease. Other therapeutic programs under development include treatments for celiac disease, Type 1 diabetes, and multiple sclerosis. The company has established research collaborations with Eli Lilly and Company and Boehringer Ingelheim to enhance its capabilities in antigen-specific tolerance induction and anti-drug antibodies, respectively. Topas Therapeutics was incorporated in 2013 and is dedicated to finding innovative solutions for chronic immunological conditions.

Televic N.V. is a Belgium-based company that specializes in developing, manufacturing, and installing advanced communication products and solutions tailored for various sectors, including healthcare, education, railways, and conferencing. Founded in 1946, Televic offers a wide range of integrated audio-visual systems for settings such as conference rooms, auditoria, and control rooms, as well as on-board communication systems and passenger information solutions for the transportation industry. The company also provides digital networks for nurse call systems, intercoms, and patient entertainment. In education, Televic delivers innovative solutions, including digital and wireless language labs, virtualized learning environments, and classroom management software. With a commitment to high-tech quality, Televic aims to expand its global presence while maintaining a leading position in its specialized markets.

AME is an independent developer and manufacturer of high quality electronic products located in the top technological region.

JenaValve Technology GmbH specializes in the development and manufacturing of transcatheter aortic valve implantation (TAVI) systems designed for both transapical and transfemoral implantation. Founded in 2006 and headquartered in Munich, Germany, the company offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The concept for the device was initiated by cardiologists Hans-Reiner Figulla and Markus Ferrari at the Friedrich Schiller University Clinic in Jena, Germany. Early on, JenaValve recognized the importance of safety, precision, and durability in their systems, which are crucial for effective treatment and enhancing patient well-being.

General Fusion Inc. is focused on developing commercial Magnetized Target Fusion (MTF), a hybrid approach that combines elements of magnetic fusion and inertial confinement fusion to create clean and abundant energy. Founded in 2002 and headquartered in Burnaby, Canada, the company aims to demonstrate and commercialize its innovative fusion technology by the end of the decade. General Fusion's approach leverages recent advancements in MTF, which has been underexplored since the 1970s, positioning it as a practical solution for near-term fusion energy. The company is developing utility-scale fusion power systems and various subsystems, including plasma injectors and acoustic drivers, to support its vision. With backing from a global network of energy venture capital funds and industry leaders, General Fusion seeks to reduce technical risks and accelerate the path toward viable fusion energy solutions.

ImCheck Therapeutics SAS is a biopharmaceutical company based in Marseille, France, founded in 2015. The company specializes in the development of immunotherapeutics aimed at addressing severe unmet medical needs, primarily in the field of immuno-oncology. ImCheck focuses on creating immuno-modulatory antibodies that target members of the butyrophilin super-family of checkpoint molecules, specifically engaging γ9δ2 T cells. Its research and development efforts are directed toward treating various cancers, including breast, gastric, and ovarian cancers, as well as other immune-related diseases. The company's innovative approach positions it at the forefront of next-generation immunotherapy solutions for patients suffering from solid tumors.

iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

Biotalys is a green biotech company that employs its proprietary Agrobody technology platform to develop crop protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. It was incorporated in 2012 and is based in Ghent, Belgium.

The Alro Group is a leading provider of coating services for the automotive industry, headquartered in Dilsen-Stokkem, Belgium. With a significant presence in Western and Central Europe, the company has evolved from a small operation into a reputable group specializing in various coating techniques. Alro Group offers a range of services including wet coating, electrocoating, powder coating, and assembly, allowing clients to obtain tailored metal and plastic products that meet their specific needs.

Smart Battery Solutions GmbH, founded in 2010 and based in Kleinostheim, Germany, specializes in the development, manufacturing, and sale of lithium-ion battery systems and charging technologies. The company focuses on low voltage applications up to 60 volts and serves various sectors, including energy production, robotics, e-mobility, nautical science, and healthcare. Its product portfolio includes a range of energy storage systems, chargers, and cells, designed for applications such as e-bikes, e-scooters, watercraft, and drones, as well as stationary solutions for constant power supply.

Camel-IDS develops radiopharmaceuticals for cancer patients. Its product, CAM-H2, treats HER2 positive cancers. It also engages in clinical development to treat breast cancer patients; and develops compounds for other cancer indications. The company was incorporated in 2014 and is based in Brussels, Belgium.

La Comtoise develops and supplies tailor-made cheese solutions to industrial food processing groups.

Medi Markt Service Nord Ost is a provider of medical aids in Germany, specializing in incontinence care, diabetes management, stoma care, enteral nutrition, tracheostomy, and various dressing materials. With over a decade of experience, the company focuses on delivering tailored solutions that meet the specific needs of patients. Their offerings also include care products and hygiene and disinfection supplies, ensuring comprehensive support for individuals managing chronic health conditions. Medi Markt Service Nord Ost aims to empower patients by providing essential resources to help them navigate their health challenges effectively.

Medi-Markt is the specialist for medical aids and care aids.

One of A Kind Technologies B.V., headquartered in Eindhoven, the Netherlands, is a holding company that specializes in camera inspection technology, vision solutions, and industrial automation products. Founded in 2012, the company has grown to include more than 65 employees across five subsidiary companies, operating globally. The company's expansion began with the acquisition of Beltech B.V., followed by VIMEC Applied Vision Technology in 2014. In subsequent years, One of A Kind Technologies established Crux Agribotics and Smart Vision Center in 2015 to explore new market opportunities and founded Uniq Engineering in 2017 to enhance turnkey engineering capabilities. The organization employs a lean model where each subsidiary manages its day-to-day operations, while the Executive Team collaborates with representatives from all disciplines to determine strategy, focusing on growth, professionalization, innovation, and synergy among the group.

Laser 2000 is an independent European suppliers of innovative laser and photonics solutions. The company's comprehensive range of products extends from lasers and light sources for the processing of materials, over measurement equipment and fibre optics to 3D imaging, optical power and energy meters as well as cameras. With more than 30 years of experience in the market, Laser 2000 is a photonics pioneer and can therefore benefit from long-standing customer and supplier relationships. It serves renowned companies and research institutes in the fields of automation and sensor technology, optical communications and network technologies, biotech and medicine, automotive and aerospace.

Impact is a temporary employment agency for specialists in technics, construction and office work. IMPACT is a specialized temporary employment agency with its headquarters in Hasselt. Their main objective? By means of a personal approach, a clear focus, and a great deal of engagement and expertise, they aim to match employers with specialists who are looking for a job in the fields of technics, construction, or office work. Thus, they contribute to the successful growth of enterprises and to the professional satisfaction of the experts who found a job thanks to them.

France Thermes Holding SAS, based in Paris, France, specializes in the design, construction, renovation, and operation of thermal resorts. Established in 2007, the group encompasses various subsidiaries, including the Thermal Resorts of Bagnoles de l'Orne in Normandy and Châtel-Guyon in Auvergne, which have been under its management since January 1, 2017. France Thermes is dedicated to the hydrotherapy industry, providing therapeutic treatments that utilize natural thermal sources. The company focuses on water-based therapies and operates healthcare spas that cater to patients seeking relief from conditions such as osteoarthritis and rheumatism, promoting a healthy lifestyle through its offerings.

Fire1, based in Dublin, Ireland, is dedicated to developing innovative therapeutic devices aimed at enhancing the lives of heart failure patients. The company has created a remote monitoring system that allows healthcare providers to access real-time patient data and insights. This technology facilitates the early detection of complications associated with heart failure, enabling proactive interventions that can lead to improved patient outcomes. Through its focus on remote monitoring, Fire1 seeks to address critical challenges in heart failure management and contribute to better healthcare solutions.

Stiplastics S.A.S. engages in designing, developing, and manufacturing medical devices for the healthcare industry

WEMAS is market leader in Germany for integrated, certified solutions for road shut-off technology. The broad range of products mainly includes shutters, fall arrestors, lights, footplates and traffic cones. The core business is supplemented by other plastic products such as mortar baths, protective devices for the logistics sector, as well as articles for horse sport. The sales are exclusively for customers as well as for the trade. At the headquarters in Gütersloh, more than 120 employees work on the satisfaction of WEMAS customers.

Cegeka is a European IT services provider specializing in ICT solutions, consultancy, and digital transformation services. Established in 1986, the company has evolved from its origins in Belgium into a significant player with a presence in ten European countries. Cegeka offers a comprehensive portfolio that includes cloud computing, cybersecurity, software development, application management, data intelligence, and IT outsourcing. With over 5,000 employees, the company operates its own data centers in Belgium and the Netherlands, providing customers with reliable IT infrastructure and support. Cegeka has achieved notable growth through strategic acquisitions and aims to help businesses navigate the complexities of the digital landscape while enhancing their operational efficiency and competitive advantage.

Arseus Medical B.V. is a distributor of medical equipment and consumables, primarily serving hospitals and healthcare professionals in the Benelux region. Established in 2002 and based in Waalwijk, the Netherlands, the company offers a wide range of products, including medical devices, disposables, hygiene and disinfection items, diagnostic materials, lab supplies, reagents, catheters, and surgical instruments. With a focus on providing efficient diagnostic and therapeutic solutions, Arseus Medical supports healthcare specialists by enhancing infrastructure and resources for improved patient monitoring and treatment, both in critical and subcritical care settings. The company distinguishes itself through exclusive distribution agreements and a commitment to delivering high-quality, innovative solutions that enhance the efficiency and effectiveness of healthcare practices, ultimately allowing professionals to concentrate on patient care. Arseus Medical, formerly known as Omega Medical BV, has a strong market presence and employs dedicated professional teams to support its customers effectively.

MVZ Holding focusses on providing best in class primary medical care and has grown successfully by executing a disciplined expansion strategy. The company currently runs more than 25 medical practices in different regions in Switzerland and plans further expansion within the country.

ImCheck Therapeutics SAS is a biopharmaceutical company based in Marseille, France, founded in 2015. The company specializes in the development of immunotherapeutics aimed at addressing severe unmet medical needs, primarily in the field of immuno-oncology. ImCheck focuses on creating immuno-modulatory antibodies that target members of the butyrophilin super-family of checkpoint molecules, specifically engaging γ9δ2 T cells. Its research and development efforts are directed toward treating various cancers, including breast, gastric, and ovarian cancers, as well as other immune-related diseases. The company's innovative approach positions it at the forefront of next-generation immunotherapy solutions for patients suffering from solid tumors.

ALT Technologies BV, established in 2002 and based in Utrecht, the Netherlands, specializes in the development and manufacturing of labeling and self-adhesive products primarily for the automotive, durable goods, and security sectors. The company's product range includes durable point-of-sale labels, product identification labels, and warning labels, as well as functional components such as light diffusion labels and various airbag parts, including covers, wraps, and inflator seals. ALT Technologies holds multi-annual contracts with major airbag producers, ensuring its products are incorporated into numerous well-known automotive brands worldwide. The company operates manufacturing facilities and sales offices in Utrecht, Romania, and Shanghai, with an additional sales office in Detroit, Michigan. ALT Technologies operates as a subsidiary of Advanced Safety Technologies B.V.

Biotalys is a green biotech company that employs its proprietary Agrobody technology platform to develop crop protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. It was incorporated in 2012 and is based in Ghent, Belgium.

Breath Therapeutics GmbH, based in Munich, Germany, with an additional office in Menlo Park, California, develops innovative drug-aerosol therapeutics aimed at treating bronchiolitis obliterans syndrome and other severe respiratory diseases. Founded in 2016 and now a subsidiary of Zambon S.p.A., the company focuses on combining novel formulations of existing drugs with advanced inhalation technologies. Their products include a liposomal formulation of cyclosporine A designed for inhalation, paired with a high-performance nebulizer that optimizes drug delivery. This approach allows for rapid delivery of high drug concentrations directly to the lungs, enhancing the efficacy of treatments while reducing systemic exposure. Breath Therapeutics aims to address significant unmet medical needs in rare pulmonary conditions through its targeted inhalation therapies.

Itineris NV is a technology company specializing in customer care and operational solutions for the energy and water sectors in Europe and North America. Established in 2003 and headquartered in Sint-Martens-Latem, Belgium, Itineris develops UMAX, a multi-commodity business solution designed for both regulated and deregulated markets, addressing utilities such as electricity, gas, water, and telecom. The company offers a range of services, including consultancy, implementation, project-based support, and long-term application management. Itineris also provides expertise in business process transformation, customer relationship management, and reporting solutions. As a Microsoft Gold Partner, Itineris leverages Microsoft’s ERP platform to enhance its offerings. The company maintains additional offices in Georgia and Maryland, and has formed strategic partnerships with industry leaders like Microsoft, IBM, and Capgemini.

MEGA International S.A., founded in 1991 and headquartered in Paris, France, specializes in software development aimed at helping organizations manage enterprise complexity. The company offers a suite of solutions under the HOPEX brand, which includes tools for business process analysis, IT portfolio management, governance, risk, compliance, and shared services. Additionally, MEGA provides HOPEX Cloud, a platform designed to facilitate business and IT transformation. The company serves a diverse clientele, including Fortune 500 companies, small and medium enterprises, and government agencies across various sectors such as banking, defense, energy, pharmaceuticals, and retail. MEGA International also offers assessment, design, implementation, support, and training services to enhance its software solutions. With a global presence supported by a network of distributors, the company is committed to helping organizations adapt to rapidly changing markets and regulatory environments while driving innovation and improving operational agility.

ACCEO operates in various sectors, primarily focusing on engineering, inspection, and certification services for buildings and large structures. The company specializes in elevator engineering and offers inspection and monitoring services for vertical transportation systems. Additionally, it conducts regulated accessibility audits and energy efficiency assessments for building owners, designers, and property managers, particularly in the commercial and administrative sectors. By providing expert advice on elevator design for both new and existing buildings, ACCEO assists its clients in enhancing the performance of their properties, reducing operational costs, and increasing overall property value. The company's services extend to the hospital market, ensuring compliance with accessibility standards and promoting energy efficiency.

Spineart Geneva SA is a medical device company based in Geneva, Switzerland, specializing in innovative solutions for spine surgery. Founded in 2005, the company focuses on developing traceable barcoded sterile packed implants and compact instrument sets for minimally invasive procedures, motion preservation, spinal fusion, biologics, and fracture treatments. Its product range includes various types of pedicle screws, cervical plates, interbody devices, and motion devices, as well as biologics such as synthetic osteoconductive gels and scaffolds. Spineart aims to enhance surgical safety and efficiency for spine surgeons and operating room teams while providing effective solutions for patients. The company's commitment to innovation is reflected in its unique patented technologies, contributing to its reputation as a pioneer in the field.

Summa Technologies, Inc. is a consulting firm that specializes in providing digital solutions to businesses across the United States. The company offers a range of services, including custom software development, which encompasses strategy and experience design, software architecture, mobile and web application development, cloud platform integration, and Internet of Things (IoT) solutions. In addition to software development, Summa provides agile transformation services and Salesforce consulting. Founded in 1996 and headquartered in Pittsburgh, Pennsylvania, Summa Technologies has formed strategic partnerships with leading companies such as Salesforce, IBM, and Microsoft. The company operates as a subsidiary of CGI Group Inc. since 2017.

Riaktr is a Belgian scale-up founded in 2009 and backed by first class investors (Fortino, Endeit, GIMV). We started as a service company under the name ‘Real Impact Analytics’. At the time, Big Data was the new big thing, driving important corporate investments. Yet, too often such investments were not yielding the desired returns. Since day one, we pursue a clear mission: leverage the value of telecom data. We do this by starting from the field to build user-centric frameworks driving results. We resist the ‘black box’ principle by putting data at the service of human intelligence and bringing teams together under a collaborative approach. Our brand Riaktr, adopted in 2018, symbolizes our pivot from a services business to a product company. Today our software products address two major questions faced by telcos: - How can I optimize my network CAPEX investments? - How can I optimize my Sales & Distribution operations? Behind the scenes, we are a team of computer scientists, engineers and business consultants based in the heart of Brussels, with a local presence close to our clients in South-Africa and Brazil. We have worked in many countries in Africa, Latin America, the Caribbean and Europe. We work with six of the ten biggest telecom groups to revolutionize the telecom and Consumer Goods industries.

EndoStim, Inc., a medical device company, develops and commercializes neurostimulation solutions for the treatment of gastro-esophageal reflux disease (GERD). Its solutions cover treatment for GERD through electrical stimulation. The company distributes its products throughout Europe, Asia, and Latin America. EndoStim was founded in 2009 and is based in Dallas, Texas.

Arplas Systems is a company focused on developing and marketing innovative welding applications primarily for the automotive industry. Founded in 1971 and headquartered in Amersfoort, the Netherlands, Arplas operates manufacturing, service, and training facilities across Europe, North America, and Korea, with additional service representatives in China and Brazil. The company specializes in welding systems that utilize a unique technology, applying minimal energy to achieve strong structural welds while significantly reducing the heat-affected zone. This approach allows automotive manufacturers to achieve energy and cost savings compared to traditional welding techniques. Arplas Systems offers a range of products, including small flanges and primary and secondary surfaces, tailored to meet the needs of car manufacturers worldwide.

Joolz designs and manufactures award-winning premium pushchairs. Joolz differentiates itself through the quality of its products and ergonomic design, as well as its unique modern brand and culture. Their stylish and distinctive pushchairs are designed to positively accommodate both child and parent. Joolz goal is to inspire young families to enjoy a positive life, i.e. a sustainable and healthy lifestyle. This aim is reflected in their ergonomic products, re-usable packaging, the Joolz Birth Forest, the partners with whom they work and the steps they take in sustainability.

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Topas Therapeutics GmbH is a biotechnology company based in Hamburg, Germany, focused on developing nanoparticle-based therapeutics to address significant unmet medical needs, particularly in autoimmune diseases, allergies, and anti-drug antibodies. The company utilizes its proprietary Topas Particle Conjugates technology platform to induce antigen-specific immune tolerance by leveraging the liver's natural immunological processes. This approach targets liver sinusoidal endothelial cells to promote tolerance against blood-borne antigens. Topas is advancing several clinical-stage programs, with its lead candidate, TPM203, currently in clinical testing for pemphigus vulgaris, an orphan disease. Other therapeutic programs under development include treatments for celiac disease, Type 1 diabetes, and multiple sclerosis. The company has established research collaborations with Eli Lilly and Company and Boehringer Ingelheim to enhance its capabilities in antigen-specific tolerance induction and anti-drug antibodies, respectively. Topas Therapeutics was incorporated in 2013 and is dedicated to finding innovative solutions for chronic immunological conditions.

Contraload is a fast growing Pan European company in pooling and rental services for plastic pallets and bins. For more than 10 years CLD has been focusing on plastic load carriers and has close to 1 million assets in its pool, all constantly on the move within the whole of Europe. CLD has a broad range of plastic pallets and IBCs for many different supply chains. Focus lies on the more complex food and FMCG supply chains with demanding and challenging global customers like Unilever, Nestle, Intersnack and many others. CLD helps its customers to meet the high quality and hygienic requirements, avoid foreign body contamination and to connect to suppliers or customers in a cost effective way. “CLD helps you carry the load”, so you can focus on your core business.

Itho Daalderop Group B.V. is a Netherlands-based company specializing in the development, manufacturing, and marketing of HVAC products for the residential sector. Founded in 1880 and operating as a subsidiary of Klimaatgarant B.V., the company offers a wide range of products including central heating systems, heat pumps, solar boilers, kitchen boilers, and ventilation systems. Itho Daalderop is dedicated to providing innovative solutions that ensure a healthy, comfortable, energy-efficient, and affordable indoor climate. The company also serves as an advisory partner to governments, corporations, and construction firms, supporting them in new construction, renovation, and replacement projects. With its headquarters in Schiedam and additional locations in Etten-Leur, Tiel, the United Kingdom, and Sint-Niklaas, Belgium, Itho Daalderop continues to expand its reach both domestically and internationally.

Legallais is a distributor of ironmongery, plumbing products and electricity products and is mainly active in the French market where it provides an exhaustive and high quality offering for craftsman, building operators and maintenance companies. Legallais is the reference in the market when it comes to service: in addition to a large product availability, customers can order in different ways (mobile, online, mail,...) and their automated logistics ensures a delivery within 24 hours.

Brakel BV specializes in manufacturing daylight access, fire safety, and ventilation solutions, including skylights, rooflights, glass louvres, facades, and various ventilation systems. Established in 1977 and based in Uden, the Netherlands, the company has maintained its position as a market leader for over 35 years, serving diverse sectors such as distribution and logistics, industry, office buildings, education, public buildings, and healthcare, both in Europe and internationally. Brakel BV also offers maintenance services for its systems, ensuring their optimal performance. Its products are distributed through a certified partner network and its project organizations in the Netherlands, Belgium, and the United Kingdom. As of late 2017, Brakel BV operates as a subsidiary of Kingspan Group plc.

Equipe Zorgbedrijven Holding B.V. operates clinics for specialized surgery in the Netherlands. The company is headquartered in Eindhoven, the Netherlands.

Biom'Up S.A. is a French company based in Saint-Priest that specializes in the development and commercialization of hemostatic products utilizing patented biopolymers and collagen technology. Established in 2005, Biom'Up designs, manufactures, and sells innovative medical devices that enhance surgical practices across various specialties, including orthopedic, spinal, cardiac, general, maxillofacial, and laparoscopic surgeries. Their flagship products, HEMOBLAST bellows and associated laparoscopic applicators, aim to simplify surgical procedures and improve patient outcomes by facilitating guided regeneration of soft tissues and bone. The company markets its offerings primarily in Europe and the United States.

JenaValve Technology GmbH specializes in the development and manufacturing of transcatheter aortic valve implantation (TAVI) systems designed for both transapical and transfemoral implantation. Founded in 2006 and headquartered in Munich, Germany, the company offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The concept for the device was initiated by cardiologists Hans-Reiner Figulla and Markus Ferrari at the Friedrich Schiller University Clinic in Jena, Germany. Early on, JenaValve recognized the importance of safety, precision, and durability in their systems, which are crucial for effective treatment and enhancing patient well-being.

CoScale NV provides software solutions for IT operations analytics. It offers integrated platform to monitor full stack of containerized applications. It also provides COSCALE Application Performance Analyzer software that gathers and correlates data from Web applications and the underlying infrastructure to automatically identify and isolate disruptions, inefficiencies, and failures in Web applications; and enable organizations to optimize its infrastructure. The company offers its product as a subscription and licensing model for organizations operating in areas, such as e-commerce, online banking, online customer service, etc. CoScale NV was founded in 2013 and is based in Ghent, Belgium.

Itineris NV is a technology company specializing in customer care and operational solutions for the energy and water sectors in Europe and North America. Established in 2003 and headquartered in Sint-Martens-Latem, Belgium, Itineris develops UMAX, a multi-commodity business solution designed for both regulated and deregulated markets, addressing utilities such as electricity, gas, water, and telecom. The company offers a range of services, including consultancy, implementation, project-based support, and long-term application management. Itineris also provides expertise in business process transformation, customer relationship management, and reporting solutions. As a Microsoft Gold Partner, Itineris leverages Microsoft’s ERP platform to enhance its offerings. The company maintains additional offices in Georgia and Maryland, and has formed strategic partnerships with industry leaders like Microsoft, IBM, and Capgemini.

United Dutch Breweries B.V., based in Breda, the Netherlands, is an independent beer group that produces and supplies a diverse range of beer and malt-based beverages. Established in 1968, the company offers various products including lagers, non-alcoholic malt beverages, dark malt beverages, ciders, and specialty beers such as stouts. It operates under several heritage brands, including Oranjeboom, 3 Horses, Royal Dutch, and Atlas, which reflect the company's rich history. United Dutch Breweries distributes its products globally through both on-trade and off-trade channels, providing consumers access to a wide selection of freshly brewed beers at competitive prices. As a former subsidiary of Anheuser-Busch InBev SA/NV, the company has established itself as a key player in the beer industry.

Teads is a leading player in the digital advertising sector, specializing in outstream video advertising. Founded in 2011 and based in New York, the company has developed a comprehensive supply side platform that allows publishers and brands to generate and monetize video inventory. This is achieved through a combination of programmatic buying, direct sales strategies, and partnerships with third parties. Teads offers innovative advertising formats and tools, including inRead formats and advanced targeting capabilities, which enhance the user experience while providing premium inventory for advertisers. With a workforce of over 600 employees across 27 global offices, Teads is recognized for its commitment to creating sustainable advertising solutions that respect user engagement. In 2017, the company became part of the Altice Group, further expanding its reach in the media and advertising landscape.

EcoChem International is a manufacturer and distributor of eco-friendly flame retardant additives, primarily serving the building and construction, transportation, and electronic sectors. The company's products are incorporated into materials such as wood, insulation, textiles, and plastics to inhibit, suppress, or delay flame and smoke production in the event of a fire. Headquartered in Olen, Belgium, EcoChem operates production facilities in Willebroek, Belgium, and Offenbach, Germany, and caters to clients across 25 countries. By offering economically viable solutions that prioritize environmental protection, EcoChem aims to meet the growing demand for sustainable fire safety products.

Well Services Group is a comprehensive provider of equipment and services for the oil and gas industry, catering to both onshore and offshore operations. The company specializes in cleaning and regenerating existing oil and gas wells using coiled tubing, and it also offers installation services for plugs and measurement equipment. With a focus on high-quality service delivery, Well Services Group utilizes well-maintained, advanced equipment and experienced personnel. Its flexible approach allows the company to quickly respond to customer needs, ensuring efficient and effective service in the petrochemical and energy sectors.

Mackevision Medien Design GmbH is one of the global market leaders in Computer Generated Imagery (CGI). It provides data-based 3D visualization, animation and visual effects. The company designs and produces image and film material, as well as interactive applications in high-end quality.It develops technological solutions for generating images and accompanies the entire CGI process from data preparation to creative design to the finished product.

MELIJOE.COM, established in 2007 by Nathalie Christen-Genty, is a leading online fashion retailer specializing in children's clothing for ages 0-16. Based in Paris, France, the platform showcases a curated selection of apparel, shoes, and accessories from renowned designers and brands, providing parents with a comprehensive shopping destination for children's fashion. With a focus on the latest trends drawn from adult runways, MELIJOE.COM offers 100% authentic products and features a user-friendly website available in six languages, ensuring a global reach. Additionally, the site incorporates an editorial strategy that includes Le Magazine, providing insights into children's fashion through exclusive shopping edits, trend reports, and in-house photo shoots, creating a vibrant digital space dedicated to young fashion enthusiasts.

Thinkstep enables organizations worldwide to succeed sustainably. Their industry-leading software, data and services drive operational excellence, product innovation, brand value and regulatory compliance. With a global presence in 19 countries they serve more than 2,000 companies, including 40 percent of the Fortune 500 such as BASF, Hewlett-Packard, Interface, Siemens, Unilever and Volkswagen.

Ablynx NV is a clinical biopharmaceutical company based in Ghent, Belgium, that specializes in the discovery and development of Nanobodies, a novel class of therapeutic proteins derived from single-domain antibody fragments. The company focuses on addressing serious human diseases, including inflammation, hematology, oncology, and respiratory conditions. Ablynx has a diverse pipeline with approximately 25 projects, featuring five Nanobodies currently in clinical development. Notable clinical programs include caplacizumab for acquired thrombotic thrombocytopenic purpura, ALX-0171 for respiratory syncytial virus infection, and Vobarilizumab for rheumatoid arthritis and systemic lupus erythematosus. Other ongoing trials involve treatments for psoriasis, solid tumors, chronic kidney diseases, and bone-loss related disorders. Ablynx has established collaboration agreements with several major pharmaceutical companies to advance its research and development efforts. Founded in 2001, Ablynx was formerly known as MatchX and rebranded in 2002. The company operates as a subsidiary of Sanofi.

JenaValve Technology GmbH specializes in the development and manufacturing of transcatheter aortic valve implantation (TAVI) systems designed for both transapical and transfemoral implantation. Founded in 2006 and headquartered in Munich, Germany, the company offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The concept for the device was initiated by cardiologists Hans-Reiner Figulla and Markus Ferrari at the Friedrich Schiller University Clinic in Jena, Germany. Early on, JenaValve recognized the importance of safety, precision, and durability in their systems, which are crucial for effective treatment and enhancing patient well-being.

Manufacturer of lingerie intended to serve women's fashion industry. The company offers plus sizes lingerie products with special attention to great support but also to finishings, fabrics and cuts, enabling customers to get fashionable and affordable products.

Transdev is a prominent operator in the public transportation sector, dedicated to providing diverse mobility solutions that empower individuals to travel freely. The company manages a wide range of transport modalities, including buses, long-haul coaches, rail services, marine transportation, and airport facilities. Transdev emphasizes local operations and decision-making, ensuring that services are tailored to meet the specific needs and expectations of its customers. By integrating advanced technology, such as applications that combine various transport options and contactless payment systems, Transdev enhances the convenience and accessibility of its services. The company is committed to delivering a high-quality travel experience, leveraging its international expertise and industry best practices while maintaining a strong focus on customer satisfaction and personalized service. Supported by its major shareholders, Transdev continues to innovate and adapt in order to meet the evolving demands of public transport.

Covagen is a biopharmaceutical company that specializes in developing bispecific FynomAbs, which are created by genetically fusing human Fynomer binding proteins to antibodies. This innovative approach results in therapeutics with unique modes of action and improved efficacy for treating inflammatory diseases and cancer. Covagen's lead product, COVA322, targets inflammatory conditions such as rheumatoid arthritis and psoriatic arthritis. The company's proprietary platform allows for the customization of FynomAbs by attaching Fynomers at multiple sites on an antibody, enabling tailored therapeutic architectures. Founded in 2007 as a spin-off from ETH Zurich, Covagen has established strategic partnerships, including a collaboration with Mitsubishi Tanabe for developing bispecific FynomAbs against specific target pairs. The company is backed by a consortium of investors, which includes notable names in the life sciences sector.

Eurocept is a healthcare company based in Ankeveen, the Netherlands, founded in 2001 by CEO Mike van Woensel. The company specializes in the registration, marketing, distribution, and sale of specialty medicines across various fields, including anesthetics, psychiatry, urology, pediatrics, and infectious diseases through its Eurocept Pharmaceuticals division. Additionally, Eurocept Homecare offers medical specialist homecare services, focusing on outpatient medical technology for the administration of medicine and nutrition. Eurocept aims to simplify the treatment relationship between medical practitioners and patients, providing comprehensive services that encompass pharmacovigilance, hospital account management, and support for pharmaceutical companies in meeting their medicinal and nursing care needs.

Almaviva Santé is a private hospital group based in Puyrucard, France, that owns and operates hospitals and healthcare clinics. Founded in 2007 and headquartered in Marseille, the company offers a wide range of medical and surgical treatments, including specialties such as orthopedics, ophthalmology, cardiology, and urology. Almaviva Santé focuses on providing comprehensive care to its patients, emphasizing safety and comfort throughout the treatment process.

Endosense is a medical technology company specializing in catheter ablation for the treatment of cardiac arrhythmias. The company has developed the TactiCath, the first and only force-sensing ablation catheter that provides physicians with a real-time, objective measure of contact force during procedures. Since receiving the CE mark in May 2009, the TactiCath has undergone extensive pre-clinical and clinical testing, establishing a strong foundation of evidence for the safety and efficacy of contact force sensing in catheter ablation. Through its innovative approach, Endosense aims to enhance the effectiveness and reproducibility of arrhythmia treatments.

NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

JenaValve Technology GmbH specializes in the development and manufacturing of transcatheter aortic valve implantation (TAVI) systems designed for both transapical and transfemoral implantation. Founded in 2006 and headquartered in Munich, Germany, the company offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The concept for the device was initiated by cardiologists Hans-Reiner Figulla and Markus Ferrari at the Friedrich Schiller University Clinic in Jena, Germany. Early on, JenaValve recognized the importance of safety, precision, and durability in their systems, which are crucial for effective treatment and enhancing patient well-being.

Complix NV is a biopharmaceutical company based in Diepenbeek, Belgium, with research facilities in Zwijnaarde, Belgium, and an office in Esch-sur-Alzette, Luxembourg. Founded in 2008, the company specializes in the discovery and development of Alphabodies, a novel class of protein therapeutics designed to target difficult disease sites, particularly in oncology and autoimmune diseases. These Alphabodies demonstrate high affinity for a variety of disease targets and possess unique stability and versatility, enabling non-injectable delivery methods. Complix aims to address challenging intracellular targets, thereby offering patients alternatives to traditional antibodies and small molecules, with the intent of improving treatment outcomes for complex conditions such as cancer, autoimmune disorders, and viral diseases.

Luciad provides high performance software tools for rapid application development of advanced systems. Our applications simplify the lives of developers and end users with advanced visual analytics that allow them to unlock the potential of real time location intelligence and create the foundations for next generation geospatial systems. From safeguarding critical assets to creating the digital infrastructure for smart cities, we help users implement intuitive command and control systems. Our customers depend on Luciad for high performance visualization that allows them to implement scalable solutions.

Marco Vasco is an online travel agency based in Paris, France, that specializes in organizing tailor-made journeys for clients seeking adventure and unique travel experiences. Founded in 2005, the company, previously known as Planetveo and Prestige Voyages, has established itself as a leader in the custom holiday market. Marco Vasco offers a wide range of travel services to diverse destinations across Asia, Africa, the Americas, Europe, and the Middle East. The agency is known for its personalized approach, providing clients with detailed itineraries, local guides, and comprehensive information on activities and accommodations. Since becoming profitable in 2010, Marco Vasco has experienced significant revenue growth, reflecting its successful adaptation to the demands of modern travelers. The company also has an office in Shanghai, China, further enhancing its international reach. As of 2017, Marco Vasco operates as a subsidiary of Société du Figaro, SAS.

Lampiris N.V., founded in 2003 and based in Liège, Belgium, is an independent supplier of electricity and gas, serving both private individuals and businesses. The company has been active in the Belgian energy market since 2005 and has established itself as the third-largest supplier in the residential sector, with over a million accounts. In addition to energy supply, Lampiris offers various energy services, including insulation, furnace maintenance, and heating solutions using wood and pellets, as well as smart thermostats. As of September 2016, Lampiris operates as a subsidiary of Elf Aquitaine S.A.

Multiplicom N.V., founded in 2010 and based in Niel, Belgium, specializes in developing molecular diagnostic test kits that facilitate the collection of genetic information for personalized treatment. The company offers a range of diagnostic assays across three main segments: human, oncology, and prenatal applications. Its human application segment includes products for cancer, genetic, and cardiovascular disorders, such as various BRCA and HNPCC assays. In oncology, Multiplicom provides kits for molecular tumor pathology and cancer genetics, including several BRCA and somatic tests. For prenatal diagnostics, the company offers the Clarigo product to detect chromosome abnormalities. Multiplicom also operates an informatics facility in Gent, Belgium, and has an additional office in Lyon, France. As of January 2017, Multiplicom N.V. is a subsidiary of Agilent Technologies, Inc.

McPhy Energy S.A. develops and supplies hydrogen production, storage, and distribution equipment for hydrogen energy, zero emission mobility, and industrial hydrogen markets worldwide. The company offers alkaline electrolyzers, including small, medium, and large hydrogen production units; and hydrogen storage solutions. It also designs medium and large hydrogen stations; and integrated hydrogen solutions. The company was founded in 2008 and is based in La Motte, France.

Biotalys is a green biotech company that employs its proprietary Agrobody technology platform to develop crop protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. It was incorporated in 2012 and is based in Ghent, Belgium.

Proxiad, established in 1997, is a consulting and expertise company specializing in new technologies and information systems. The company focuses on enhancing organizational productivity through a variety of services, including custom application development, mobile technology solutions, and workflow management. Proxiad is committed to digital innovation and supports its 710 employees in their professional growth, ensuring they remain current with technological advancements. This approach fosters a motivating and human-centered work environment while enabling clients to receive tailored assistance in their ongoing professional development.

Jeeng is a product developed by PowerInbox, Inc., a company that specializes in multichannel digital monetization solutions for publishers and marketers. Jeeng focuses on enhancing user engagement through automated push notifications and email alerts, leveraging real-time capabilities to revitalize static mail programs. The platform integrates seamlessly with existing email programs, allowing marketers, agencies, and email service providers to implement personalized and targeted campaigns effectively. By combining dynamic animation and geographic targeting, Jeeng aims to improve click-through rates and overall user interaction. Founded in 2010 and based in New York, PowerInbox continues to provide innovative solutions backed by leading venture capital firms.

Endosense is a medical technology company specializing in catheter ablation for the treatment of cardiac arrhythmias. The company has developed the TactiCath, the first and only force-sensing ablation catheter that provides physicians with a real-time, objective measure of contact force during procedures. Since receiving the CE mark in May 2009, the TactiCath has undergone extensive pre-clinical and clinical testing, establishing a strong foundation of evidence for the safety and efficacy of contact force sensing in catheter ablation. Through its innovative approach, Endosense aims to enhance the effectiveness and reproducibility of arrhythmia treatments.

Ambit Biosciences is a privately-held biopharmaceutical company dedicated to the discovery and development of small molecule kinase inhibitors aimed at treating cancer, inflammatory diseases, and other conditions. The company's lead compound, AC220, is a selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor currently undergoing clinical trials for patients with relapsed or refractory acute myeloid leukemia (AML). Ambit is collaborating with Astellas Pharma Inc. to jointly develop and commercialize FLT3 kinase inhibitors across various indications. The clinical pipeline also includes AC480, a pan-HER inhibitor, and AC430, an oral JAK2 inhibitor. In addition, Ambit has several preclinical candidates, including CEP-32496, a BRAF inhibitor that has been licensed to Cephalon. Through its innovative research, Ambit aims to improve treatment outcomes for patients suffering from cancer.

GOVECS, established in 2009, focuses on the development, production, and marketing of electric vehicles, emphasizing clean and efficient transportation solutions. The company is committed to delivering reliable and affordable electric mobility options, with a team of top engineers and designers dedicated to creating stylish zero-emission scooter models. GOVECS aims to be at the forefront of electrical mobility technology, contributing to sustainable transportation solutions.

Movea is a provider of motion sensing and data fusion software, firmware, and IP for the consumer electronics, particularly smart phones and tablets, sports and fitness and eHealth industries. Movea's proprietary SmartMotion™ technology - unique motion processing capabilities - enable customers and partners to quickly add motion intelligence to their products, providing reduced risk, cost, and time-to-market advantages for delivering compelling new motion-based features that create more value and a more exciting user experience for the consumer. Movea has a global presence with headquarters in Grenoble, France, a U.S. subsidiary in Silicon Valley, California, as well as technology and manufacturing partners and distributors around the world. The company was recently named a “Cool Vendor for 2012” by leading analyst firm Gartner Inc. Movea, Inc. was formerly known as Gyration, Inc. and changed its name to Movea, Inc. in January 2008. The company was founded in 1989 and is based in Milpitas, California. As of December 21, 2007, Movea, Inc. operates as a subsidiary of Movea SA.

ARS Traffic & Transport Technology has been providing traffic and transport technology solutions to businesses and government bodies since 1997. It is active in its home market of the Netherlands, but also internationally. The intelligent transport system market is always on the move, in every sense of the word. A dynamic market like this demands a specialised partner, able to cost-effectively integrate state-of-the-art, client-specific technology with existing systems, but also able to develop new hi-tech concepts.

Prosonix Ltd. operates as a specialty pharmaceutical company, which develops and markets a portfolio of inhaled respiratory medicines to treat asthma and chronic obstructive pulmonary diseases. It develops generic mono and combination therapies based on inhaled corticosteroids (ICS), long-acting beta agonists (LABA), and long-acting muscarinic antagonists (LAMA); and dual and triple combination therapies for respiratory diseases based on its multiple-component particle technology. The company was founded in 2006 and is based in Oxford, United Kingdom. As of June 15, 2015, Prosonix Ltd. operates as a subsidiary of Circassia Limited.

NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

GreenWatt is a CleanTech company specializing in the development of anaerobic digestor plants that convert organic waste into renewable energy. The company provides comprehensive engineering services, including feasibility studies, construction, and the startup of turn-key small-scale biogas plants. Utilizing innovative and patented technologies, GreenWatt addresses key challenges associated with anaerobic digestion. Its installations are designed to integrate locally within the agro-food and beverage industries, offering a cost-effective and efficient solution for waste management and energy production.

Oldelft B.V. is a manufacturer based in Delft, Netherlands, specializing in transesophageal echocardiography (TEE) ultrasound transducers. The company produces a variety of probes, including adult multiplane TEE transducers, motorized adult multiplane probes, mini-multi pediatric transducers, and micro-multi TEE probes. These devices are utilized in the adult, pediatric, and neonatal cardiology markets for the diagnosis and monitoring of heart conditions, facilitating high-quality imaging via the esophagus. Oldelft is recognized for its expertise in the miniaturization of transducers, making it a leading independent supplier of complex ultrasound components that cater to both children and adults. The company is also engaged in ongoing research and development projects in collaboration with various technical and medical universities, focusing on innovative product designs to enhance its offerings.

Prosensa is a biopharmaceutical company that specializes in the discovery, development, and commercialization of RNA-based therapeutics. It is particularly focused on addressing genetic disorders, with a primary emphasis on neuromuscular conditions. The company recognizes significant market opportunities in the healthcare sector for innovative products targeting genetic disorders, anti-infectives, and oncology. To maximize commercial potential, Prosensa plans to leverage its strong intellectual property position while primarily outsourcing its operations to specialized organizations. Through this strategy, the company aims to develop novel therapeutics that can address unmet medical needs in various therapeutic areas.

Pronota NV is developing and commercialising first-in-class diagnostics for early detection of life-threatening conditions and unmet medical needs including heart failure, pre-eclampsia and sepsis. Pronota's non-invasive, validated, diagnostics are proprietary and focused on improving quality of care for patients. Backed by a solid base of investors including GIMV, LSP, KBC Private Equity and JJDC, and a wide network of renowned key opinion leaders, Pronota is committed to making a difference in diagnosis and personalized healthcare. Pronota NV was formerly known as Peakadilly NV and changed its name to Pronota NV in November 2006. The company was founded in 2004 and is based in Zwijnaarde, Belgium.

VCST is a world-class automotive supplier of precision-machined powertrain and brake components for Automotive OEM’s and Tier 1 suppliers. The company realized a turnover of 169 million euro in 2015 and employs 1250 full time employees. VCST has production facilities in Belgium, China, Germany, Mexico and Romania, with its headquarters located in Belgium.

Trustteam NV is a provider of comprehensive information technology solutions for businesses, established in 2002 and headquartered in Kortrijk, Belgium, with additional locations in Heusden-Zolder and Paris. The company specializes in a range of services including cloud solutions, security, telephony, software, hardware, and IT consulting. Trustteam focuses on delivering outsourced IT management services that address various technology-related challenges faced by enterprises. By offering a complete suite of services, including security awareness training and digitization, Trustteam helps clients from diverse industries streamline their operations and concentrate on their core business activities, effectively alleviating their IT concerns.